- 論 文
- Hiratsuka Y, Tagami K, Inoue A, Sato M, Matsuda Y, Kosugi K, Kubo E, Natsume M, Ishiki H, Arakawa S, Shimizu M, Yokomichi N, Chiu SW, Shimoda M, Hirayama H, Nishijima K, Ouchi K, Shimoi T, Shigeno T, Yamaguchi T, Miyashita M, Morita T & Satomi E. Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study. Supportive Care in Cancer. 2023 16 Oct; 31:632.
- Tagami K, Chiu SW, Kosugi K, Ishiki H, Hiratsuka Y, Shimizu M, Mori M, Kubo E, Ikari T, Arakawa S, Eto T, Shimoda M, Hirayama H, Nishijima K, Ouchi K, Shimoi T, Shigeno T, Yamaguchi T, Miyashita M, Morita T, Inoue A, Satomi E. Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services. Journal of Pain and Symptom Management. 2023 18 Sep; S0885-3924(23)00684-X.
- Mishima T, Chiu SW, Saiki H, Yamaguchi T, Shimo Y, Maeda T, Watanabe H, Kashihara K, Nomoto M, Hattori N, Tsuboi Y. Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST. Journal of the Neurological Sciences. 2023;448:120619.
- Motoyama S, Hosaka M, Kamei T, Ueno M, Watanabe M, Ohkura Y, Mine S, Tanabe S, Toyokawa T, Wakita A, Nishikawa K, Ninomiya I, Fujita K, Kanda1 M, Hirai M, Hoshi M, Chiu SW, Takata M, Yamaguchi T, Miura M. A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma. Anticancer Res. 2022 ;42: 6105-6112
- Takayama S, Yoshino T, Koizumi S, Irie Y, Suzuki T, Fujii S, Katori R, Kainuma M, Kobayashi S, Nogami T, Yokota K, Yamazaki M, Minakawa S, Chiba S, Suda N, Nakada Y, Ishige T, Maehara H, Tanaka Y, Nagase M, Kashio A, Komatsu K, Nojiri M, Shimooki O, Nakamoto K, Arita R, Ono R, Saito N, Kikuchi A, Ohsawa M, Nakae H, Mitsuma T, Mimura M, Ishii T, Nochioka K, Chiu SW, Yamaguchi T, Namiki T, Hisanaga A, Mitani K, Ito T. Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-Observation) [published online ahead of print, 2022 Nov 2]. Intern Med. 2022 Nov 2.
- Oyamada S, Chiu SW, Yamaguchi T. Comparison of statistical models for estimating intervention effects based on time-to-recurrent-event in stepped wedge cluster randomized trial using open cohort design. BMC Med Res Methodol 22, 123 (2022).
- Shimo Y, Maeda T, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H. Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST). Parkinsonism Relat Disord. 2021 Oct;91:115-120.
- Oda T, Chiu SW, Yamaguchi T. Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning. Methods Inf Med 2021; 60(01/02): 049-061.
- Yamada O, Chiu SW, Takata M, Abe M, Shoji M, Kyotani E, Endo C, Shimada M, Tamura Y, Yamaguchi T. Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verification. Clin Trials. 2021 Apr;18(2):158-167.
- Watanabe H, Saiki H, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Maeda T, Shimo Y. Real-world non-motor changes in patients with Parkinson's disease and motor fluctuations: J-FIRST: J-FIRST: non-motor symptoms in PD. Movement Disorders Clinical Practice. 2020. doi: 10.1002/mdc3.12939.
- Tanaka H, Chiu SW, Watanabe T,Kaoku S,Yamaguchi T. Computer-aided diagnosis system for breast ultrasound images using deep learning. Physics in Medicine & Biology. 2019. 64(23) 235013.
- Ishii T, Tanaka Y, Kawakami A, Saito K, Ichinose K, Fujii H, Shirota Y, Shirai T, Fujita Y, Watanabe R, Chiu SW, Yamaguchi T, Harigae H; Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus. Modern rheumatology. 2018 Nov;28(6):986-992.
- Maeda T, Shimo Y, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H. Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers. Parkinsonism Relat Disord 2017;38:54-60.
- 著書/訳書
－
- 学会発表
国内学会：
- Shih-Wei Chiu, 山口拓洋. Adjusting Time-Varying Confounding by Marginal Structural Model in Observational Study. 第24回日本薬剤疫学会学術総会. 2018年10月13日-14日.＜口演発表 奨励賞＞
- Shih-Wei Chiu,高橋史朗,高木愛理,山口拓洋,下川宏明. AROにおける解析プロセスの標準化と効率向上～TLFを優先に～. 日本臨床試験研究会第9回学術集会総会．2018年2月23日-24日.
国際学会：
- Shih-Wei Chiu,Takuhiro Yamaguchi, on behalf of the J-FIRST group. How To Imply The Needs Of Marginal Structural Model To Clinicians: An Application In Parkinson's Disease - From A Junior Statistician's Aspect -. 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.Aug 24-28,2019.
- Shih-Wei Chiu,Takuhiro Yamaguchi, on behalf of the J-FIRST group. Dealing with Time-Varying Confounding by Marginal Structural Model in Observational Study: An Application in Parkinson’s Disease. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.Aug 22-26,2018.
- Shih-Wei Chiu,Takuhiro Yamaguchi,on behalf of the J-FIRST group. The Use of Group-based Trajectory Models to Characterize Longitudinal Patterns of Nonmotor Symptoms in Patients with Parkinson’s Disease in Japan. 33th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.Aug 26-30,2017.
- Chiu S.W.,Yamada K,Yoshikuni Y,Kirihara M,Yoshizaki M,Yoshida M,Kamon T,Kono H,Misawa T, Nishiyama K, Yamamoto N, Fukimbara S, Hayashi Y,Miyaji T,Otoguro T,Suganami H,Yamada T,Yamaguchi T. After Official CDISC Training, What Is the Next Step? -Practical Training Program for Data Manager-. Society for Clinical Data Management 2017 Annual Conference.Sep 24-27,2017 ＜SCDM2017 Poster Presentation 3rd Prize was received.＞
- シンポジウム等
－
|
